To assess the association of BC progression with aberrant expression of miRNAs that target ER and PR mRNAs, we quantified miR-19b, -222, -22, -378a, and -181a in BC samples (<i>n</i> = 174) by real-time PCR. The gene discussed is ESR1; the disease is breast cancer.